Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Vera Therapeutics, Inc.
Company profile

Vera Therapeutics, Inc.

NASDAQ: VERA · Healthcare · Biotechnology
PublicHQ Brisbane, CA · San MateoCIK 0001831828Reports USD
#1 of 1,394 Healthcare companies by revenue
EA Score
——
FH 55DQ —GM —SS 59
v0.1 · 35/100 weight · pillars only
↑ Altman-Z, market scale · ↓ Piotroski F, listing tenure
Methodology →
Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$299.6M
Employees
152
Market cap
$3.0B
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Net income-$299.6M-$299.6M2025
Operating income-$315.5M-$315.5M2025
Total assets$734.7M$734.7M2025
Liabilities$130.2M$130.2M2025
Equity$604.5M$604.5M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Vera Therapeutics, Inc. earned -$299.6M in FY2025 net income.

Peers · Healthcare
GRAIL Inc.51DAcadia Healthcare Company, Inc.67BDisc Medicine, Inc.——Arcus Biosciences, Inc.47D
Neighbors
San Mateo →
Meta Platforms, Inc.$201.0B87AGilead Sciences, Inc.$29.4B87ARobinhood Markets, Inc.$4.5B67BEquinix, Inc.$9.2B73BElectronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$052D
Key facts
CEOGary Barrera
SectorHealthcare
IndustryBiotechnology
HeadquartersBrisbane, CA
ExchangeNASDAQ: VERA
Employees152
IPO date2021-05-14
Latest filings
8-K2026-07-098-K2026-07-078-K2026-06-028-K2026-05-2610-Q2026-05-078-K2026-05-07DEF 14A2026-04-098-K2026-03-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies